Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
07/2012
07/19/2012US20120184569 A3 adenosine receptor agonists and antagonists
07/19/2012US20120184568 Processes for preparing isoquinolinones and solid forms of isoquinolinones
07/19/2012US20120184565 Compounds for the reduction of beta-amyloid production
07/19/2012US20120184562 1,6- and 1,8-naphthyridines
07/19/2012US20120184560 Molecular diagnostic methods for predicting brain metastasis of breast cancer
07/19/2012US20120184557 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
07/19/2012US20120184556 Substituted enzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
07/19/2012US20120184548 Carboxylic acid aryl amides
07/19/2012US20120184546 [1,2,4]triazolo [1,5-c]pyrimidine derivatives as hsp90 modulators
07/19/2012US20120184543 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
07/19/2012US20120184542 Pyrido pyrimidines
07/19/2012US20120184541 Compounds and methods of use
07/19/2012US20120184540 1,4 oxazines as bace1 and/or bace2 inhibitors
07/19/2012US20120184535 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
07/19/2012US20120184534 Tri-cyclic pyrazolopyridine kinase inhibitors
07/19/2012US20120184533 Small molecule inhibitors of parp activity
07/19/2012US20120184530 Dimeric IAP Inhibitors
07/19/2012US20120184529 Combination therapy
07/19/2012US20120184526 Compounds and compositions as syk kinase inhibitors
07/19/2012US20120184524 Pyrazolopyridine kinase inhibitors
07/19/2012US20120184523 C-Met Modulators and Method of Use
07/19/2012US20120184515 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases
07/19/2012US20120184505 Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
07/19/2012US20120184498 Dermaseptin b2 used as an inhibitor of the growth of a tumor
07/19/2012US20120184496 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
07/19/2012US20120184495 Targeted nano-photomedicines for photodynamic therapy of cancer
07/19/2012US20120184494 Multiple myeloma prognosis and treatment
07/19/2012US20120184493 Dermal formulations of dp2 receptor antagonists
07/19/2012US20120184482 Novel Ubiquitin-Isopeptide Probes
07/19/2012US20120184481 Variants of pigment epithelium derived factor and uses thereof
07/19/2012US20120184480 Use of constrained dipeptide and tripeptide mimic oligomers as vectorization agents
07/19/2012US20120183636 Anti-cancer composition comprising aquatic microbial extract
07/19/2012US20120183621 Synergistic combinations to reduce particle dose for targeted treatment of cancer and its metastases
07/19/2012US20120183613 Novel Pharmaceutical Composition
07/19/2012US20120183604 Treatment of Triple Receptor Negative Breast Cancer
07/19/2012US20120183603 Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
07/19/2012US20120183601 Compositions And Methods For Regulation Of Tumor Necrosis Factor-Alpha
07/19/2012US20120183600 Novel composition for treating metabolic syndrome and other conditions
07/19/2012US20120183598 Hla-a2 tumor associated antigen peptides and compositions
07/19/2012US20120183596 Encapsulation of Plasmid DNA (Lipogenes) and Therapeutic Agents with Nuclear Localization Signal/Fusogenic Peptide Conjugates into Targeted Liposome Complexes
07/19/2012US20120183579 Compounds for inflammation and immune-related uses
07/19/2012US20120183578 Polyethylene glycol-based dendrons
07/19/2012US20120183575 Exosome based treatment of cancer
07/19/2012US20120183574 Modified vaccinia virus ankara for the vaccnation of neonates
07/19/2012US20120183566 Aldehyde-Tagged Immunoglobulin Polypeptides and Methods of Use Thereof
07/19/2012US20120183564 Inhibition of endosomal toll-like receptor activation
07/19/2012US20120183560 Monoclonal Antibodies
07/19/2012US20120183558 Antibody molecules which bind il-17a and il-17f
07/19/2012US20120183555 Serum markers associated with early and other stages of breast cancer
07/19/2012US20120183554 Biomarker
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183549 Chemokine receptor binding polypeptides
07/19/2012US20120183547 Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease
07/19/2012US20120183546 Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
07/19/2012US20120183544 Diagnosis and treatment of neuroectodermal tumors
07/19/2012US20120183543 Diagnostic biomarkers for fibrotic disorders
07/19/2012US20120183539 Cancer Metastasis Inhibitor
07/19/2012US20120183538 Sparc antisense compositions and uses thereof
07/19/2012US20120183537 1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer
07/19/2012US20120183536 Methods of using corticotropin-releasing factor for the treatment of cancer
07/19/2012US20120183535 use of inhibitors of bruton's tyrosine kinase (btk)
07/19/2012US20120183532 Compounds stimulating undesirable cellular adhesion and applications thereof
07/19/2012US20120183523 Methods and Compounds for Promoting Vessel Regression
07/19/2012US20120183522 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
07/19/2012US20120183509 Microglial precursor cells for the treatment of malignant neoplasms of the central nervous system
07/19/2012US20120183472 Immunotherapy of b-cell malignancies using anti-cd22 antibodies
07/19/2012US20120183471 Specific binding proteins and uses thereof
07/19/2012CA2860862A1 Methods and compositions for treating cancer and related methods
07/19/2012CA2824779A1 Substituted benzoazepines as toll-like receptor modulators
07/19/2012CA2824760A1 Imidazo [4, 5 -c] quinolin- 2 -one compound and its use as pi3 kinase / mtor dual inhibitor
07/19/2012CA2824743A1 Use of simalikalactone e as an anticancer agent
07/19/2012CA2824706A1 Pharmaceutical compositions for the treatment of parasitic diseases, cancer, or skin diseases by topical administration
07/19/2012CA2824480A1 Anticancer therapy with dual aurora kinase / mek inhibitors
07/19/2012CA2824438A1 Use of toll-like receptor agonist for treating cancer
07/19/2012CA2824417A1 Pharmaceutical composition for treating cancer
07/19/2012CA2824324A1 Mirna for treating diseases and conditions associated with neo-angiogenesis
07/19/2012CA2824293A1 5-(1,2,3-triazol-4-yl)-7h-pyrrolo[2,3-d]pyrimidine derivatives
07/19/2012CA2824143A1 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
07/19/2012CA2818933A1 Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
07/19/2012CA2817757A1 Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers, and liver health maintenance
07/18/2012EP2476752A1 Process for production of natural killer cells
07/18/2012EP2476704A2 Humanized monoclonal antibodies to heptocyte growth factor
07/18/2012EP2476699A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476698A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476697A2 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
07/18/2012EP2476695A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476694A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476693A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476692A2 Peptide vaccines for cancers expressing tumor-associated antigens
07/18/2012EP2476683A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
07/18/2012EP2476682A1 8-oxodihydropurine derivative
07/18/2012EP2476667A2 Aminoheteroaryl compounds as protein kinase inhibitors
07/18/2012EP2476461A2 Formulations For Cancer Treatment
07/18/2012EP2476440A1 Therapeutic compositions for the treatment of hpv-induced diseases
07/18/2012EP2476438A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4)
07/18/2012EP2476427A2 A method of treating cancer comprising a VEGF-B antagonist
07/18/2012EP2475779A1 Detecting pax2 for the diagnosis of breast cancer
07/18/2012EP2475769A1 Inhibition of histone acetyltransferases by ctk7a and methods thereof
07/18/2012EP2475673A1 Cyclobutan-1,1 -dicarboxylato complexes of platinum with n6-benzyladenine derivatives, method of their preparation and application of these complexes as drugs in antitumour therapy
07/18/2012EP2475668A1 Ether derivatives of bicyclic heteroaryls
1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 2211